Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicholas Wiebe"'
Autor:
Angela MY Chan, Emeka Enwere, John B McIntyre, Holly Wilson, Chidera Nwaroh, Nicholas Wiebe, Young Ou, Shuhong Liu, Katharina Wiedemeyer, Peter F Rambau, Xin Grevers, Donald G Morris, Paola Neri, C Blake Gilks, Frank Visser, Nhu Le, Li Luo, Linda S Cook, Martin Köbel
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 6, Iss 4, Pp 252-262 (2020)
Abstract CCNE1 amplification is a recurrent alteration associated with unfavourable outcome in tubo‐ovarian high‐grade serous carcinoma (HGSC). We aimed to investigate whether immunohistochemistry (IHC) can be used to identify CCNE1 amplification
Externí odkaz:
https://doaj.org/article/6ee18146a012411aa9e07aebf83b2262
Autor:
Gregg Nelson, Christa Aubrey, Michael S. Anglesio, Nicholas Wiebe, Cheng-Han Lee, Martin Köbel, Sandra Lee, Derek Tilley, Prafull Ghatage, Eun Young Kang
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 8, Iss 1, Pp 19-32 (2022)
The Journal of Pathology: Clinical Research
The Journal of Pathology: Clinical Research
The World Health Organization endorses molecular subclassification of endometrial endometrioid carcinomas (EECs). Our objectives were to test the sensitivity of tumor morphology in capturing p53 abnormal (p53abn) cases and to model the impact of p53a
Autor:
Shuhong Liu, Holly E Wilson, John B. McIntyre, Paola Neri, Young Ou, Chidera Nwaroh, C. Blake Gilks, Donald Morris, Martin Köbel, Li Luo, Frank Visser, Emeka K. Enwere, Peter F Rambau, Katharina Wiedemeyer, Xin Grevers, Linda S. Cook, Nicholas Wiebe, Nhu D. Le, Angela My Chan
Publikováno v:
The Journal of Pathology: Clinical Research
The Journal of Pathology: Clinical Research, Vol 6, Iss 4, Pp 252-262 (2020)
The Journal of Pathology: Clinical Research, Vol 6, Iss 4, Pp 252-262 (2020)
CCNE1 amplification is a recurrent alteration associated with unfavourable outcome in tubo‐ovarian high‐grade serous carcinoma (HGSC). We aimed to investigate whether immunohistochemistry (IHC) can be used to identify CCNE1 amplification status a
Publikováno v:
Diagnostic Pathology
Background Few larger studies have evaluated the long-term outcome after a diagnosis of papillary urothelial neoplasm of low malignant potential (PUNLMP), demonstrating a broad range of recurrence and progression rates. Additionally, no study has add